Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,911 | 16,564 | 37,449 | 43,507 | 32,236 |
| Marketable Securities | 157,269 | 77,511 | 78,161 | 130,290 | 146,978 |
| Receivables | 16,677 | 14,785 | 24,080 | 19,285 | 13,463 |
| Inventories | 5,948 | 6,157 | 5,870 | 5,747 | 5,406 |
| TOTAL | $231,933 | $123,975 | $148,933 | $204,351 | $204,612 |
| Non-Current Assets | |||||
| PPE Net | 2,722 | 3,001 | 3,180 | 3,328 | 3,382 |
| Intangibles | 91,062 | 110,780 | 112,747 | 40,200 | 40,765 |
| Other Non-Current Assets | 26,144 | 15,521 | 12,567 | 11,281 | 9,929 |
| TOTAL | $119,928 | $129,302 | $128,494 | $54,809 | $54,076 |
| Total Assets | $351,861 | $253,277 | $277,427 | $259,160 | $258,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 114 | 111 | 301 | 291 | 272 |
| Accounts payable and accrued liabilities | 15,906 | 7,477 | 8,564 | 12,321 | 7,962 |
| Accrued Expenses | 45,948 | 50,926 | 47,997 | 30,339 | 19,936 |
| Other current liabilities | 23,333 | 25,604 | 31,493 | 41,848 | 44,524 |
| TOTAL | $87,185 | $86,539 | $97,308 | $88,709 | $84,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | 111,724 | 156 | 614 | 594 | 555 |
| Deferred Revenues | 1,884 | 2,007 | 1,927 | 2,455 | 1,617 |
| Other Non-Current Liabilities | 65,898 | 81,002 | 83,042 | 93,129 | 115,002 |
| TOTAL | $177,622 | $81,158 | $83,656 | $93,723 | $115,557 |
| Total Liabilities | $264,807 | $167,697 | $180,964 | $182,432 | $199,606 |
| Shareholders' Equity | |||||
| Common Shares | 420 | 414 | 414 | 414 | 414 |
| Retained earnings | -274,921 | -262,685 | -254,440 | -276,119 | -305,046 |
| Other shareholders' equity | -22,828 | -23,627 | -22,927 | -23,018 | -23,391 |
| TOTAL | $87,054 | $85,580 | $96,463 | $76,728 | $59,082 |
| Total Liabilities And Equity | $351,861 | $253,277 | $277,427 | $259,160 | $258,688 |